Nephrocalcinosis and phosphate supplementation in a preterm infant.
Short
A
A
Institute of Child Health, Royal Liverpool Childrens Hospital, Alder Hey, United Kingdom.
Shaw
N J
NJ
Weindling
A M
AM
D005665:Furosemide / Q000009:adverse effects; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000139:chemically induced*; D008297:Male; D009397:Nephrocalcinosis / Q000139:chemically induced*; D010710:Phosphates / Q000009:adverse effects*
D010710:Phosphates; D005665:Furosemide